Recon

JOINT-REPLACEMENT DEVICES A SOCIETAL BARGAIN

Biloine W. Young • Mon, July 7th, 2014

We read a lot about the costs of medical technology to patient care but a closer look reveals that medical technology prices in the United States have remained consistently low for 20 years. According to Jeffrey R. Binder, president and CEO of Biomet Inc. and a member of the board of directors at the Advanced Medical Technology Association, writing for the online publication Phily.com, medical technology prices have grown at about an average annual rate of 1%—half the rate of prices in the overall economy.

Binder writes that spending on advanced medical technology, as a percentage of national health expenditures, has also remained virtually constant from 1992 to 2010. Total joint-replacement devices are going down in price. From 2007 to 2011 the average inflation-adjusted price paid by hospitals for artificial hips declined by 23% and the cost for knee implant devices fell by 17%.

Binder refers to studies that have shown that Medicare patients receiving total hip or knee replacements have nearly half the risk of death after seven years compared with a matched group of osteoarthritis patients who had not received total joint replacements.

Binder quotes a study showing that, for the average patient, the direct costs of knee replacement surgery are offset by indirect savings from increased employment and earnings, fewer missed days at work, and lower disability payments. The result is a lifetime net benefit of nearly $19,000 per patient. If applied across all U.S. knee recipients in 2009, the study estimated net lifetime societal savings of $12 billion just from treatment delivered in that year alone.

READ THE REST AT RYORTHO

Tags

Josh Sandberg

Josh Sandberg is the President of Ortho Sales Partners and Partner for The De Angelis Group. He also serves as Co-Founder and Editor of OrthoSpineNews.

Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *

Close